Hemmingsen, J.K.; Enemark, M.H.; Pedersen, A.K.N.; Sørensen, E.F.; Lauridsen, K.L.; Løhde, J.B.; d’Amore, F.; Hamilton-Dutoit, S.J.; Bjerre, M.; Ludvigsen, M.
Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies. Int. J. Mol. Sci. 2025, 26, 11248.
https://doi.org/10.3390/ijms262311248
AMA Style
Hemmingsen JK, Enemark MH, Pedersen AKN, Sørensen EF, Lauridsen KL, Løhde JB, d’Amore F, Hamilton-Dutoit SJ, Bjerre M, Ludvigsen M.
Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies. International Journal of Molecular Sciences. 2025; 26(23):11248.
https://doi.org/10.3390/ijms262311248
Chicago/Turabian Style
Hemmingsen, Jonas Klejs, Marie Hairing Enemark, Anne Kathrine Nissen Pedersen, Emma Frasez Sørensen, Kristina Lystlund Lauridsen, Julie Bondgaard Løhde, Francesco d’Amore, Stephen Jacques Hamilton-Dutoit, Mette Bjerre, and Maja Ludvigsen.
2025. "Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies" International Journal of Molecular Sciences 26, no. 23: 11248.
https://doi.org/10.3390/ijms262311248
APA Style
Hemmingsen, J. K., Enemark, M. H., Pedersen, A. K. N., Sørensen, E. F., Lauridsen, K. L., Løhde, J. B., d’Amore, F., Hamilton-Dutoit, S. J., Bjerre, M., & Ludvigsen, M.
(2025). Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies. International Journal of Molecular Sciences, 26(23), 11248.
https://doi.org/10.3390/ijms262311248
